Substance Use Prevention for Youth With Parents in Recovery
2 other identifiers
interventional
80
1 country
1
Brief Summary
Risk for substance use disorder (SUD) begins early in the life course. Although preventing and decreasing illicit and nonmedical drug use among youth is an urgent public health priority, there are currently few evidence-based prevention strategies feasible for delivery in the primary care setting. The investigators propose a three-year plan to collect critical pilot data to pilot test and optimize a dyadic intervention that aims to increase family resilience, strengthen coping skills, help families plan for the future, and prevent youth SUD. The 'prototype' for the intervention approach is Family Talk, an evidence-based parent-youth dyadic intervention that can be delivered within the existing infrastructure of the patient-centered medical home. The investigators have made preliminary adaptations to the model in preparation for testing. To prepare for a subsequent efficacy study, a two-arm pilot randomized controlled trial of the intervention with 40 parent-youth dyads to optimize the intervention model will be conducted. The feasibility of the intervention will be evaluated. In addition, empiric estimates of study parameters to inform the planning of a fully powered randomized controlled trial and plausible intervention targets using semi-structured qualitative interviews will be obtained.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2022
CompletedFirst Posted
Study publicly available on registry
May 31, 2022
CompletedStudy Start
First participant enrolled
August 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedDecember 11, 2024
December 1, 2024
1.6 years
May 23, 2022
December 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Participation metrics
The number of families approached and screened for the project, number ineligible, number refusing participation, and number ultimately enrolled will be assessed
12 months
Reasons for not enrolling
An investigator created questionnaire will be obtain the reasons why eligible potential participants did not enroll in the study.
12 months
Study attrition rates
The percent of participants will be calculated by dividing the number of participants that complete the study by the total number of participants enrolled.
12 months
Number of sessions
The number of sessions delivered by the intervention providers will be tracked.
throughout the study up to 12 months
Person-time of sessions
The total and average person time for sessions delivered by the intervention providers will be tracked.
throughout the study up to 12 months
Secondary Outcomes (11)
Youth substance use in preceding 90 days
90 days
Youth substance use screening
12 months
Family Communication
3 months, 6 months, 12 months
Family Functioning
3 months, 6 months, 12 months
Depression
3 months, 6 months, 12 months
- +6 more secondary outcomes
Study Arms (2)
Intervention refinement arm
EXPERIMENTAL20 parent-youth \[12-18 years old\] dyads will be randomized to this arm and receive the Modified Family Talk intervention.
Parameter estimation arm
EXPERIMENTAL20 parent-youth dyads randomized to this control-like arm will receive current best practice care in the patient-centered medical home
Interventions
The Modified Family Talk intervention consists of six modules, each lasting approximately 60 minutes. Family Talk is intended to be delivered over a period of 12 weeks, with meetings occurring every 1-2 weeks.
Parameter estimation is designed to emulate best practices around comprehensive, high quality, patient-centered care for adults and youth. Participants will have access to collaborative adult Office Based Addiction Treatment (OBAT) clinical services, multidisciplinary adolescent primary care clinics with co-located adolescent substance use specialists, high quality social work services, integrated behavioral health, and access to patient navigators for assistance connecting to community resources.
Eligibility Criteria
You may qualify if:
- years without diagnosed SUD
- Comfortable speaking English or Spanish
- years or older
- Receiving treatment for SUD
- Receiving substance use care in the CODAC system
- Comfortable speaking English or Spanish
You may not qualify if:
- Presence of acute family crisis, such as recent death, incarceration, separation, divorce, or other stressor
- Parent or youth with cognitive limitation or intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
CODAC
Pawtucket, Rhode Island, 02904, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline J Kistin, MD MSc
Brown University School of Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2022
First Posted
May 31, 2022
Study Start
August 29, 2024
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
December 11, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
Upon completion of study analyses and publications, the investigators will make data and non-publishable documentation (such as research protocols, data collection instruments, other findings) available to internal and external bona fide researchers upon request in a timely fashion. The de-identified data will be made available to others only after discussion with the study team and under a formal data-sharing agreement that provides for: 1. commitment to use data for research purposes only and not to identify individual study participants; 2. commitment to use appropriate information technology systems to keep data secure; and 3. commitment to returning or destroying data after analyses are complete. The research team will also work with the Boston University Medical Campus Institutional Review Board (IRB) to assure protection of confidentiality, as necessary.